Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep108 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2017

Stress cardiomyopathy in pheochromocytoma

Gheorghiu Cristina Alexandra , Jercalau Simona , Badiu Corin

Introduction: Rare cases of pheochromocytoma are associated with stress induced Takotsubo cardiomyopathy explained by high catecholamine exposure causing microvascular spasm and direct myocardial impact.Case report: A 49-year-old female with a history of poorly controlled hypertension, with paroxysmal elevations in blood pressure and rare supraventricular extrasystoles, lipothymic events, was firstly assessed in the cardiologic department. She presented ...

ea0049ep1395 | Thyroid (non-cancer) | ECE2017

Stimulated calcitonin levels as a predictor of medullary thyroid cancer

Alexandra Gheorghiu Cristina , Corneci Cristina , Jercalau Simona , Dobrescu Ruxandra , Mihai Daniel , Badiu Corin

Abstract: Medullary thyroid cancer (MTC) is a highly aggressive neuroendocrine tumour originating in the thyroid parafollicular cells. Calcitonin measurement and RET gene ascertainment have been used as markers for early diagnosis of MTC. Since pentagastrin is not available, calcium stimulation test helps to preclude ‘gray zone’ values of basal calcitonin, diagnose minimal residual disease and help the early diagnosis of C cell hyperplasia.Aim:...

ea0035p734 | Neuroendocrinology | ECE2014

Efficacy of early postoperative radiotherapy for nonfunctioning null cell or silent pituitary macroadenomas

Stancu Cristina , Gheorghiu Monica Livia , Galoiu Simona , Anghel Rodica , Badiu Corin , Coculescu Mihail

Background: Suitable postoperative radiotherapy (RT) of nonfunctioning pituitary macroadenomas (NFMAs) is still controversial, subjected to rapid technical and medical progress.Patients and methods.: We studied 87 patients with NFMA to identify factors affecting tumor control such as the time of RT and tumor pathology. Partial pituitary surgery was performed either by transfrontal (30 patients) or transsphenoidal (57 patients) approach. An immunoperoxida...

ea0056p1010 | Endocrine tumours and neoplasia | ECE2018

Thresholds of basal and calcium stimulated calcitonin for diagnosis of medullary thyroid carcinoma

Baetu Mara , Gheorghiu Cristina , Corneci Cristina , Ioachim Dumitru , Caragheorgheopol Andra , Dobrescu Ruxandra , Badiu Corin

Introduction: The current revised medullary thyroid carcinoma (MTC) guidelines don’t specify reference ranges of basal (bCT) or stimulated serum calcitonin (sCT) levels for the diagnosis of MTC. These are important for early diagnosis and correct management.Objective: We aimed to set gender specific thresholds for bCT and sCT for MTC diagnosis.Patients and methods: CT samples during calcium-stimulation test (2...

ea0056p1200 | Thyroid cancer | ECE2018

RET exon 11 genotype in medullary thyroid cancer

Muresan Andrei , Radian Serban , Ghervan Cristina , Gheorghiu Monica , Paun Diana , Baciu Ionela , Ioachim Dumitru , Padure Adriana , Dobrescu Ruxandra , Manda Dana , Badiu Corin

Introduction: RET mutation is a well-known pathogenic event in medullary thyroid cancer. However, less than 25% of MTC cases present a germline mutation. First grade relatives of the patients with germline RET mutations may undergo genetic counselling and prophylactic appropriate therapeutic intervention.Objective: The aim of the study was to evaluate the most frequent pathogenic RET exon 11 mutations and SNP in medullary thyroid cancer (MTC).<p clas...